Actively Recruiting
Post-market Clinical Trial of the Dominus® Stent-Graft
Led by Braile Biomedica Ind. Com. e Repr. Ltda. · Updated on 2024-08-22
100
Participants Needed
3
Research Sites
279 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use
CONDITIONS
Official Title
Post-market Clinical Trial of the Dominus® Stent-Graft
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Patients treated with the Dominus4 Stent-Graft Endoprosthesis following its Instructions for Use
- Available for appropriate follow-up during the study
- Provided informed consent after being informed about the study
You will not qualify if you...
- Currently participating in another clinical study of a drug or medical device
- Life expectancy less than 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Hospital Evangélico de Vila Velha
Vila Velha, Espírito Santo, Brazil, 29118-060
Not Yet Recruiting
2
Hospital Nossa Senhora da Conceição
Porto Alegre, Rio Grande do Sul, Brazil, 91350-200
Actively Recruiting
3
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Ribeirão Preto, São Paulo, Brazil, 14048-900
Actively Recruiting
Research Team
G
Glaucia Basso
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here